V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008882 | 260005864 | 1.66 | 98.3 | Disease modification (D) | 2016-01-25 | 2016-01-26 | Cisplatin + Etoposide (5 day) | N | N | 260028794 | PACIFICO TRIAL |
| 260008883 | 260012067 | null | 62.2 | Palliative (P) | 2013-10-28 | 2013-10-31 | Rituximab (Maintenance) | 01 | N | 260028795 | RITUXIMAB |
| 260008884 | 260005865 | 1.62 | 56 | Curative (C) | 2016-07-10 | 2016-07-18 | PACIFICO TRIAL | N | N | 260028797 | GALLIUM TRIAL |
| 260008885 | 260005866 | 1.61 | 50 | Palliative (P) | 2013-09-28 | 2013-10-22 | IVE | N | N | 260028798 | RITUXIMAB |
| 260008886 | 260005866 | 1.73 | null | null | null | 2013-06-08 | Carboplatin + Etoposide IV 3 day | null | null | 260028798 | RITUXIMAB |
| 260008887 | 260005867 | 1.9 | 102.9 | Palliative (P) | 2015-05-15 | 2015-05-15 | Rituximab | N | N | 260028800 | TRIAL |
| 260008888 | 260005868 | 1.59 | 49.9 | Palliative (P) | 2017-12-19 | 2017-12-22 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | 02 | N | 260028805 | RITUXIMAB |
| 260008889 | 260005868 | 1.66 | null | Curative (C) | 2014-10-04 | 2014-10-06 | Rituximab | 02 | N | 260028805 | CARBOPLATIN + PACLITAXEL |
| 260008890 | 260005868 | null | 90.1 | Unknown (U) | 2014-09-04 | 2014-09-04 | INTERFERON | 2 | N | 260028805 | CISPLATIN + FLUOROURACIL + RT |
| 260008891 | 260005868 | 1.84 | 94 | Disease modification (D) | 2014-05-04 | 2014-05-12 | Chlorambucil | N | N | 260028805 | GEMCITABINE |
| 260008892 | 260005869 | 1.6 | 77 | Curative (C) | 2015-05-27 | 2015-05-28 | Rituximab | N | N | 260028815 | ABVD |
| 260008893 | 260012070 | 1.78 | 86.2 | Palliative (P) | 2013-09-19 | 2013-09-19 | RCEOP | 02 | N | 260028818 | RITUXIMAB |
| 260008894 | 260012070 | null | 94.3 | Curative (C) | null | 2018-02-21 | CYCLOPHOSPHAMIDE | N | N | 260028818 | RITUXIMAB |
| 260008895 | 260012070 | 1.7 | 60.6 | Palliative (P) | 2016-12-23 | 2016-12-23 | Rituximab | null | N | 260028818 | CHOP |
| 260008896 | 260005870 | 1.77 | null | Palliative (P) | 2016-08-31 | 2016-09-07 | CHOP - 21 days | N | N | 260028823 | PACIFICO TRIAL |
| 260008897 | 260005870 | 1.72 | 61.6 | Adjuvant (A) | 2014-05-15 | 2014-05-16 | Rituximab | N | N | 260028823 | AZACITIDINE |
| 260008898 | 260005870 | 1.88 | null | Curative (C) | 2016-11-18 | 2016-11-18 | DOXORUBICIN + IFOSFAMIDE | 02 | N | 260028823 | CISPLATIN + ETOPOSIDE |
| 260008899 | 260005871 | 1.67 | 82.5 | Curative (C) | 2016-12-28 | 2017-01-03 | EP | null | N | 260028828 | PACIFICO TRIAL |
| 260008900 | 260005871 | 1.72 | null | Curative (C) | 2014-05-19 | 2014-06-07 | Rituximab | N | N | 260028828 | RITUXIMAB |
| 260008901 | 260005872 | 1.69 | 47 | null | 2017-05-21 | 2017-05-25 | Hydroxycarbamide | N | null | 260028831 | RITUXIMAB |
| 260008902 | 260005872 | null | 0 | null | null | 2016-03-20 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | null | null | 260028831 | CISPLATIN + RT |
| 260008903 | 260005872 | null | 70 | Curative (C) | null | 2017-02-06 | Rituximab | null | null | 260028831 | CHOP |
| 260008904 | 260005872 | 1.67 | 132.6 | null | 2014-04-18 | 2014-04-21 | R Chlorambucil | 02 | null | 260028831 | RITUXIMAB |
| 260008905 | 260005873 | 1.77 | 92.2 | Adjuvant (A) | 2013-11-04 | 2013-11-07 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 2 | N | 260028844 | ETOPOSIDE |
| 260008906 | 260005873 | 1.8 | 57 | Palliative (P) | 2018-02-24 | 2018-03-05 | Nilotinib | 1 | N | 260028844 | CHLORAMBUCIL + RITUXIMAB |
| 260008907 | 260015578 | 1.65 | 0 | Curative (C) | 2018-10-09 | 2018-10-15 | Chlorambucil | 02 | N | 260028846 | GALLIUM TRIAL |
| 260008908 | 260017418 | 1.63 | 72.7 | Curative (C) | 2014-04-05 | 2014-04-07 | ICE-R (Cycle 2 onwards) | 2 | Y | 260028848 | RITUXIMAB |
| 260008909 | 260005874 | null | null | Disease modification (D) | 2017-04-11 | 2017-04-12 | ECX | 02 | N | 260028849 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008910 | 260012075 | 1.75 | 68.2 | null | 2018-08-31 | 2018-09-02 | Rituximab | 02 | null | 260028851 | BENDAMUSTINE |
| 260008911 | 260012075 | 1.88 | null | Disease modification (D) | 2015-03-23 | 2015-03-27 | Cisplatin | 02 | N | 260028851 | TIP |
| 260008912 | 260005875 | null | 59.2 | Palliative (P) | 2015-02-20 | 2015-02-21 | Rituximab | 2 | N | 260028854 | RITUXIMAB |
| 260008913 | 260005875 | 1.9 | 68 | Curative (C) | 2017-11-04 | 2017-11-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 260028854 | NOT MATCHED |
| 260008914 | 260005876 | 1.66 | 110 | Curative (C) | 2013-08-12 | 2013-09-05 | Rituximab | 02 | N | 260028857 | RITUXIMAB |
| 260008915 | 260005876 | 1.59 | 69.2 | Palliative (P) | null | 2016-05-15 | Cisplatin + Radiotherapy | Y | N | 260028857 | RITUXIMAB |
| 260008916 | 260005877 | 1.73 | 70.8 | Curative (C) | 2018-05-07 | 2018-05-07 | BENDAMUSTINE | 02 | N | 260028860 | RITUXIMAB |
| 260008917 | 260005877 | null | null | null | 2014-08-30 | 2014-08-30 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 260028860 | RITUXIMAB |
| 260008918 | 260005877 | null | 96.8 | null | 2017-03-13 | 2017-03-16 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | N | 260028860 | RITUXIMAB |
| 260008919 | 260005877 | 1.74 | null | Disease modification (D) | 2016-05-23 | 2016-05-26 | CISPLATIN + FLUOROURACIL | N | N | 260028860 | CAPECITABINE + CISPLATIN |
| 260008920 | 260005878 | 1.71 | 90.6 | Palliative (P) | 2015-09-07 | 2015-09-20 | Capecitabine + Oxaliplatin 21day | 02 | N | 260028865 | CARBOPLATIN + ETOPOSIDE |
| 260008921 | 260005878 | 1.85 | 73 | Palliative (P) | 2013-10-18 | 2013-11-12 | RCEOP | N | N | 260028865 | ECX |
| 260008922 | 260005878 | 1.58 | 71.5 | null | 2016-04-09 | 2016-04-09 | Chlorambucil | N | N | 260028865 | CHLVPP |
| 260008923 | 260005878 | null | 80 | Palliative (P) | 2017-06-07 | 2017-06-16 | CAPECITABINE + OXALIPLATIN | N | N | 260028865 | GALLIUM TRIAL |
| 260008924 | 260005878 | 1.74 | 100 | null | 2019-02-06 | 2019-02-08 | Rituximab | 01 | null | 260028865 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 260008925 | 260005879 | 1.82 | null | Disease modification (D) | 2017-07-20 | 2017-08-12 | Rituximab (SUBCUTANEOUS Maintenance) | N | N | 260028875 | IMATINIB |
| 260008926 | 260005879 | 1.81 | null | Curative (C) | 2017-05-26 | 2017-05-26 | Trial Unspecified | Y | N | 260028875 | PACIFICO TRIAL |
| 260008927 | 260005880 | 1.88 | 67.2 | Curative (C) | 2013-09-19 | 2013-09-29 | Rituximab | N | N | 260028879 | ICE-R |
| 260008928 | 260012081 | 1.77 | null | null | 2017-08-16 | 2017-08-26 | BENDAMUSTINE | N | N | 260028881 | RITUXIMAB |
| 260008929 | 260005881 | 1.67 | null | Palliative (P) | 2017-01-08 | 2017-01-28 | BEAM | N | N | 260028885 | CHLORAMBUCIL |
| 260008930 | 260005882 | 1.59 | 73.6 | Palliative (P) | 2016-06-15 | 2016-06-15 | Rituximab | 2 | N | 260028887 | MPV |
| 260008931 | 260012082 | 1.72 | null | Curative (C) | 2015-03-11 | 2015-03-11 | LEAM | N | N | 260028890 | CAPECITABINE + OXALIPLATIN |